GeneDx Holdings Corp. (WGSWW)

Market Cap	1.97B
Revenue (ttm)	330.14M
Net Income (ttm)	-38.58M
Shares Out	28.53M
EPS (ttm)	-1.41
PE Ratio	n/a
Forward PE	54.93
Dividend	n/a
Ex-Dividend Date	n/a

Volume	86,299
Open	0.0729
Previous Close	0.0639
Day's Range	0.0610 - 0.0729
52-Week Range	0.0202 - 0.3410
Beta	2.01
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 18, 2025

About WGSWW

GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company also develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. The company is headquartered in Stamford, Connecticut.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2017
• Employees: 1,000
• Stock Exchange: NASDAQ
• Ticker Symbol: WGSWW
• Website: https://www.genedx.com

Financial Performance

In 2024, GeneDx Holdings's revenue was $305.45 million, an increase of 50.79% compared to the previous year's $202.57 million. Losses were -$52.29 million, -70.25% less than in 2023.